Celyad Oncology

+$0.37 (+7.96%) Today
-$0.01 (-0.20%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYAD and other ETFs, options, and stocks.

About CYAD

Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology.

CEO
Filippo Joseph Petti
Employees
92
Headquarters
Mont-Saint-Guibert, Walloon Region
Founded
2007

CYAD Key Statistics

Market Cap
78.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
41.65K
High Today
$5.02
Low Today
$4.45
Open Price
$4.61
Volume
102.24K
52 Week High
$10.31
52 Week Low
$3.76

CYAD Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Mar 23
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure